×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Dianthus Therapeutics Presents Future Outlook at Conference - TipRanks.com
Tipranks
Dianthus Therapeutics (DNTH) has shared an update. Starting June 6, 2024, Dianthus Therapeutics, Inc. will unveil an updated corporate presentation at...
1 day ago
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 6.3%
MarketBeat
Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) traded down 6.3% on Thursday . The company traded as low as $21.14 and...
1 day ago
The Zacks Analyst Blog Highlights American Eagle Outfitters, Abercrombie & Fitch, Cimpress, Dianthus Therapeutics ...
Yahoo Finance
American Eagle Outfitters, Abercrombie & Fitch, Cimpress, Dianthus Therapeutics and NVIDIA Corporation are part of the Zacks top Analyst...
2 months ago
Insider Stock Buying Reaches US$2.05m On Dianthus Therapeutics
Simply Wall Street
Over the last year, a good number of insiders have significantly increased their holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH).
1 month ago
Dianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated by Analysts at HC Wainwright
Defense World
Read Dianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated by Analysts at HC Wainwright at Defense World.
3 weeks ago
Dianthus Therapeutics Appoints Adam Veness, Esq., as General Counsel
PR Newswire
PRNewswire/ -- Dianthus Therapeutics, a clinical-stage biotechnology company dedicated to advancing the next generation of antibody...
11 months ago
Catalio Capital Management Joins $230 Million Investment in Dianthus Therapeutics
citybiz
NEW YORK and WALTHAM, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology...
4 months ago
Magenta Therapeutics: Potential Upside In The Merger, Wait To Buy More (MGTA)
Seeking Alpha
Magenta Therapeutics, a previously promising biotech firm, halted operations following a clinical trial tragedy. Read more about MGTA stock...
10 months ago
Insider Buying: Fairmount Funds Management LLC Acquires 24,254 Shares of Dianthus Therapeutics Inc
Yahoo Finance
On September 13, 2023, Fairmount Funds Management LLC, a Director and 10% Owner of Dianthus Therapeutics Inc (NASDAQ:DNTH), purchased 24254...
8 months ago
Dianthus Therapeutics Secures $230M in Private Placement - TipRanks.com
Tipranks
Dianthus Therapeutics (DNTH) has released an update to notify the public and investors about an entry into a material definitive agreement.
4 months ago